PoC Study to Evaluate the Efficacy and Safety of Secukinumab 300 mg in Patients With Lichen Planus
Clinical trial NCT04300296 · COMPLETED
Trial details
- NCT number
- NCT04300296
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2021-11-16
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.